2024-09-01 2025-08-31 false Capium Accounts Production 1.1 14303587 2024-09-01 2025-08-31 14303587 bus:AbridgedAccounts 2024-09-01 2025-08-31 14303587 bus:FRS102 2024-09-01 2025-08-31 14303587 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 14303587 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 14303587 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 14303587 2024-09-01 2025-08-31 14303587 2025-08-31 14303587 bus:RegisteredOffice 2024-09-01 2025-08-31 14303587 core:WithinOneYear 2025-08-31 14303587 core:AfterOneYear 2025-08-31 14303587 1 2024-09-01 2025-08-31 14303587 bus:Director1 2024-09-01 2025-08-31 14303587 bus:Director1 2025-08-31 14303587 bus:Director1 2023-09-01 2024-08-31 14303587 bus:Director2 2024-09-01 2025-08-31 14303587 bus:Director2 2025-08-31 14303587 bus:Director2 2023-09-01 2024-08-31 14303587 2023-09-01 14303587 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 14303587 2023-09-01 2024-08-31 14303587 2024-08-31 14303587 core:WithinOneYear 2024-08-31 14303587 core:AfterOneYear 2024-08-31 14303587 bus:EntityAccountantsOrAuditors 2023-09-01 2024-08-31 14303587 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 14303587 bus:OrdinaryShareClass1 2025-08-31 14303587 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 14303587 bus:OrdinaryShareClass1 2024-08-31 14303587 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 14303587 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 14303587 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 14303587 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 14303587 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 14303587 core:Non-currentFinancialInstruments 2025-08-31 14303587 core:Non-currentFinancialInstruments 2024-08-31 14303587 core:ShareCapital 2025-08-31 14303587 core:ShareCapital 2024-08-31 14303587 core:RetainedEarningsAccumulatedLosses 2025-08-31 14303587 core:RetainedEarningsAccumulatedLosses 2024-08-31 14303587 dpl:Item1 2024-09-01 14303587 dpl:Item1 2025-08-31 14303587 dpl:Item1 2023-09-01 14303587 dpl:Item1 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14303587
England and Wales
KARAM MEDICS LTD
Abridged Accounts
Period of accounts Start date: 01 September 2024 End date: 31 August 2025

Karam Medics Ltd Contents Page For the year ended 31 August 2025
Statement of financial position | 1
Notes to the financial statements | 2

Karam Medics Ltd Statement of Financial Position As at 31 August 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Current assets |  |  |
Cash at bank and in hand |  | 24,119 |  | 59,853
Creditors: amount falling due within one year |  | (14,624) |  | (40,909)
Net current assets |  | 9,495 |  | 18,944
Total assets less current liabilities |  | 9,495 |  | 18,944
Net assets |  | 9,495 |  | 18,944
Capital and reserves |  |  |
Called up share capital | 3 | 100 |  | 100
Profit and loss account |  | 9,395 |  | 18,844
Shareholders' funds |  | 9,495 |  | 18,944
For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 15 January 2026 and were signed on its behalf by:
------------------------------- Muhammad Tahir Director
1

Karam Medics Ltd Notes to the Abridged Financial Statements For the year ended 31 August 2025
General Information Karam Medics Ltd is a private company, limited by shares, registered in England and Wales, registration number 14303587, registration address 49 Brooklands Close, Bedfordshire, Luton, LU4 9EH. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 2 (2024 : 2).
3. | Share Capital
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
2